Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial.
OBJECTIVE
To assess the effect of general practitioner testing for C reactive protein (disease approach) and receiving training in enhanced communication skills (illness approach) on antibiotic prescribing for lower respiratory tract infection.


METHODS
Pragmatic, 2x2 factorial, cluster randomised controlled trial.


METHODS
20 general practices in the Netherlands.


METHODS
40 general practitioners from 20 practices recruited 431 patients with lower respiratory tract infection.


METHODS
The primary outcome was antibiotic prescribing at the index consultation. Secondary outcomes were antibiotic prescribing during 28 days' follow-up, reconsultation, clinical recovery, and patients' satisfaction and enablement.


METHODS
General practitioners' use of C reactive protein point of care testing and training in enhanced communication skills separately and combined, and usual care.


RESULTS
General practitioners in the C reactive protein test group prescribed antibiotics to 31% of patients compared with 53% in the no test group (P=0.02). General practitioners trained in enhanced communication skills prescribed antibiotics to 27% of patients compared with 54% in the no training group (P<0.01). Both interventions showed a statistically significant effect on antibiotic prescribing at any point during the 28 days' follow-up. Clinicians in the combined intervention group prescribed antibiotics to 23% of patients (interaction term was non-significant). Patients' recovery and satisfaction were similar in all study groups.


CONCLUSIONS
Both general practitioners' use of point of care testing for C reactive protein and training in enhanced communication skills significantly reduced antibiotic prescribing for lower respiratory tract infection without compromising patients' recovery and satisfaction with care. A combination of the illness and disease focused approaches may be necessary to achieve the greatest reduction in antibiotic prescribing for this common condition in primary care.


BACKGROUND
Current Controlled Trials ISRCTN85154857.
Cals
Jochen W L
JW
Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, Netherlands. j.cals@hag.unimaas.nl
Butler
Christopher C
CC
Hopstaken
Rogier M
RM
Hood
Kerenza
K
Dinant
Geert-Jan
GJ
D000328:Adult; D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D016000:Cluster Analysis; D003142:Communication; D005194:Family Practice / Q000193:education*; D005260:Female; D006801:Humans; D008297:Male; D017060:Patient Satisfaction; D019095:Point-of-Care Systems; D010818:Practice Patterns, Physicians'; D011361:Professional Competence / Q000592:standards*; D012141:Respiratory Tract Infections / Q000097:blood / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D015415:Biomarkers; D002097:C-Reactive Protein